Compare · ALXN vs EIDX
ALXN vs EIDX
Side-by-side comparison of Alexion Pharmaceuticals, Inc. (ALXN) and Eidos Therapeutics, Inc. (EIDX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALXN and EIDX operate in Major Pharmaceuticals (Health Care), so they compete in similar markets.
- Company
- Alexion Pharmaceuticals, Inc.
- Eidos Therapeutics, Inc.
- Price
- -
- -
- Market cap
- -
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Major Pharmaceuticals
- Major Pharmaceuticals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1996
- 2018
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 0
Latest ALXN
- Resolution Therapeutics appoints Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer
- SEC Form 15-12G filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
Latest EIDX
- BIOMEA Fusion Strengthens its Executive Team with Appointment of Franco Valle as Chief Financial Officer
- BridgeBio Pharma, Inc. Reports Fourth Quarter And Full Year 2020 Financial Results And Business Update
- SEC Form 15-12B filed
- SEC Form 4: C Jonathan Fox gifted 500 units of Common Stock, decreasing ownership by 100% to 0 units
- SEC Form 4 filed by Douglas Rohlen
- SEC Form 4 filed by Franco Valle
- SEC Form 4: Cameron Turtle decreased ownership by 100% to 0 units
- SEC Form 4 filed by J. Ali Satvat
- SEC Form 4 filed by William Lis
- SEC Form 4 filed by Sawochka Suzanne Hooper